Close Menu

Derek Lowe at In the Pipeline is not so sure that academia is the place for translational research, as both "the process of turning an interesting idea into a real drug target" and that of "turning an interesting compound into a real drug … involve a lot of laborious detail work, of the kind that does not mint fresh PhDs nor energize the postdocs." However, because the National Institutes of Health has recently expressed increased interest in supporting translational research — most recently by funding Clinical and Translational Science Awards at new academic sites, as our sister publicatio

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.